MANUFACTURER: CAPITAL BIO TECHNOLOGY
MADE: CHINA
TYPE: NEXT GENERATION SEQUENCING PLATFORMS
CapitalBio®BioelectronSeq 4000 Sequencer uses semiconductor chip sequencing technology in conjunction with clinical testing kits and automated analysis software to provide independent genetic testing in hospitals and medical labs.
The sequencer uses semiconductor sequencing technology to determine the base sequence in real-time by detecting the PH change caused by the H+ ion flow generated during DNA replication. It is appropriate for independent genetic testing in hospitals when combined with clinical testing kits and automated analysis software.
FEATURES:
1. Flexible sequencing throughput:
The base sequence is determined using the cutting-edge semiconductor chip sequencing technique by monitoring the pH shift induced by the flow of H+ ions created during DNA replication in real-time. Depending on the type of chip you choose, you can generate anywhere from 10Gb to 60Gb of data with a single run, making it ideal for use in clinical testing laboratories.
2. Short sequencing time:
The entire sequencing process can be completed more than three times a day in less than two hours, allowing laboratory staff to maximize their time and increase productivity.
3. Long sequencing reads length:
Sequencing may detect cell-free DNA in peripheral blood with a read length of 200 bp on average and up to 300 bp at its maximum.
4. Strong scalability:
In order to accommodate a wide range of sequencing read lengths and data throughputs, users need just select sequencing chips with varying throughputs rather than reworking their instruments' core hardware.
5. User-friendly interface:
It's easy to use and master in a single day of training.
